Pogled radioterapevta onkologa na zdravljenje raka želodca

Show document
A+ | A- | | SLO | ENG

Title:	Pogled radioterapevta onkologa na zdravljenje raka želodca
Authors:	ID Oblak, Irena (Author)
Files:	PDF - Presentation file, download (498,68 KB) MD5: 95B9745D1E56550AE20D66B3236D8268 PID: 20.500.12556/dirros/00acf76d-e509-4fbd-9f0c-a746cec68a54
Language:	Slovenian
Typology:	1.08 - Published Scientific Conference Contribution
Organization:	OI - Institute of Oncology
Keywords:	radioterapija, rak želodca, radiologija, rak prebavil
Publication status:	Published
Publication version:	Version of Record
Year of publishing:	2014
Number of pages:	str. 39-44, 74
Numbering:	Letn. 18, št. 1
PID:	20.500.12556/DiRROS-8702
UDC:	616.3-006
ISSN on article:	1408-1741
URN:	URN:NBN:SI:doc-DV6ISH45
COBISS.SI-ID:	1808251
Copyright:	by Authors
Publication date in DiRROS:	31.08.2018
Views:	3764
Downloads:	979
Metadata:
:	OBLAK, Irena, 2014, Pogled radioterapevta onkologa na zdravljenje raka želodca. In : Šola: tumorji prebavil II, Ljubljana, 15. 11. 2013 [online]. Published Scientific Conference Contribution. 2014. p. 39–44, 74. [Accessed 13 April 2025]. Retrieved from: https://dirros.openscience.si/IzpisGradiva.php?lang=eng&id=8702 Copy citation

Share:

Similar works from our repository:

Similar works from other repositories:

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Title:	Šola: tumorji prebavil II, Ljubljana, 15. 11. 2013
Publisher:	Onkološki inštitut
COBISS.SI-ID:	1807227

License:	CC BY 4.0, Creative Commons Attribution 4.0 International

Link:	http://creativecommons.org/licenses/by/4.0/
Description:	This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:	31.08.2018

Language:	English
Title:	[The radiation therapy oncologist's view of gastric cancer treatment]
Abstract:	Gastric cancer is associated with a poor prognosis. At diagnosis, approximately 50% of patients have a non-resectable disease. In patients who underwent radical resection, the disease recurs in as many as 75%, of which 40-64% are local and/or regional recurrences (2-4). Despite this fact, we are observing that survival of patients has improved over the years. According to the SLORE data, relative 5-year survival was 14.7% in 1985, 17.8% in 1995, 22.1% in 2000 and 25.6% in 2005 (5). Surgical resection of the tumour and regional lymph nodes is the method of choice for treating gastric cancer with no distant metastases. Until 2000, it was also the only treatment method.